Figure 1 : Bar-plot of segmental and total Bone Mineral Density (BMD, g/cm2) measured using the Dual-energy X-ray Absroptiometry (DXA) technique for Healthy Control women (n=100), Non-Metastatic Breast Cancer women before (n=100) and after (n=97) receiving 6-cycles of a three-drug Cyclophosphamide, Adriamycin, and 5-Fluoruoracil (CAF) chemotherapy alone and before (n=100) and after (n=99) receiving CAF + Vitamin D treatment protocols.

*p<0.05 versus Before CAF, **p<0.01 versus After CAF+Vit D and Healthy Control and• ••p<0.01 versus Before CAF+Vitamin D and Healthy Control, respectively.

Mohamed et al.Breast Cancer Reports  2019 6:1DOI : 10.7243/2057-1631-6-1